^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
zeushield cytotoxic T lymphocyte therapy
i
Other names: zeushield cytotoxic T lymphocyte therapy, autologous T cells modified chimeric antigen receptor targeting PD-L1/CD80/CD86, Z-CTL therapy, Z-CTLs, Zeushield Cytotoxic T Lymphocytes
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Hunan Yongren Medical Innovation, Hunan Zhaotai Yongren
Drug class:
PD-L1-targeted CAR-T immunotherapy, CD80-targeted CAR-T immunotherapy, CD86-targeted CAR-T immunotherapy
Related drugs:
